|
|||||
|
|
Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia |
|
| Authors: | Ping-Tao Tseng Mu-Hong Chen Chih-Sung Liang |
| Affiliation: | Ping-Tao Tseng, Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, TaiwanMu-Hong Chen, Department of Psychiatry, Taipei Veterans General Hospital, Taipei 112, TaiwanChih-Sung Liang, Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei 112, Taiwan |
| Abstract: | We read the impressive review article “Clozapine resistant schizophrenia: Newer avenues of management” with great enthusiasm and appreciation. The author believes that preventing clozapine resistance from developing may be the most effective treatment strategy for patients with clozapine-resistant schizophrenia (CRS), and optimizing clozapine treatment is a key component. Disentangling the differences between treatment-resistant schizophrenia and CRS is important for studies addressing treatment strategies for these difficult-to-treat populations. |
| Keywords: | Treatment-resistant schizophrenia Clozapine Clozapine-resistant schizo-phrenia Ultra-resistant schizophrenia Ultra-treatment-resistant schizophrenia Super-refractory schizophrenia |
| 点击此处可从《World Journal of Psychiatry》浏览原始摘要信息 | |